At a glance
- Originator Kyowa Hakko
- Class Anti-ischaemics; Antiasthmatics; Bronchodilators; Cardiotonics; Vasodilators
- Mechanism of Action Phosphotransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma; Ischaemic heart disorders
Most Recent Events
- 07 Jun 2001 Discontinued-Preclinical for Asthma in Japan (Unknown route)
- 07 Jun 2001 Discontinued-Preclinical for Ischaemic heart disorders in Japan (Unknown route)
- 31 Aug 1998 No-Development-Reported for Asthma in Japan (Unknown route)